1. Targeting Glutathione S-transferase M4 in Ewing sarcoma
   Rupeng Zhuo et al, 2014, Frontiers in Pediatrics CrossRef
2. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
   Zhangjian Huang et al, 2017, Journal of Medicinal Chemistry CrossRef
3. Fifty Years of Diazeniumdiolate Research: A Tribute to Dr. Larry K. Keefer
   Khosrow Kashfi, 2023, Critical Reviews™ in Oncogenesis CrossRef
4. Development of JS-K, a First-in-Class Arylated Diazeniumdiolate, for the Treatment of Cancer
   Paul J. Shami, 2023, Critical Reviews™ in Oncogenesis CrossRef
5. JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin
   Mingning Qiu et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef